Prokidney Corp (PROK) Stock Price, Quote & News

Company Profile

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2...

Industry: Biotechnology

Sector: Healthcare

Phone: 336 999 7028

Website: prokidney.com

Address:

2000 Frontis Plaza Blvd., Suite 250, Winston-Salem, United States

Biohacker Jan. 26 at 8:17 PM

$PROK 💩

0 · Reply

wavridr Jan. 21 at 7:39 PM

$PROK fuuuuuk! It was so close! 🤬🤬🤬

0 · Reply

wavridr Jan. 21 at 7:14 PM

$PROK finally! This POS is going back to where it belongs🎉💥

0 · Reply

Biohacker Jan. 21 at 4:45 PM

$PROK 💩

0 · Reply

SmartWentCrazy Jan. 20 at 5:04 PM

$PROK

0 · Reply

Biohacker Jan. 20 at 3:53 PM

$PROK 💩

0 · Reply

Strizzball Jan. 18 at 1:04 PM

$PROK https://www.msn.com/en-us/health/other/food-drug-experts-say-new-kidney-cell-therapy-could-transform-chronic-disease-treatment/ar-AA1Uj1VX

0 · Reply

Biohacker Jan. 15 at 3:28 PM

$PROK 💩

0 · Reply

wavridr Jan. 15 at 3:23 PM

$PROK by tmrw this POS will finally be below 2 😁😂😂

0 · Reply

Biohacker Jan. 13 at 5:42 PM

$PROK 💩

0 · Reply

ProKidney Corp. (PROK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 6, 2026, 7:30 AM EST - 21 days ago

ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nov 10, 2025, 4:15 PM EST - 2 months ago

ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

Nov 6, 2025, 11:00 AM EST - 2 months ago

ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025

Oct 29, 2025, 7:30 AM EDT - 3 months ago

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

Oct 20, 2025, 7:30 AM EDT - 3 months ago

ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025

Sep 19, 2025, 10:52 AM EDT - 4 months ago

ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy

Sep 8, 2025, 10:14 AM EDT - 5 months ago

ProKidney Corp. (PROK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 3, 2025, 2:08 PM EDT - 5 months ago

ProKidney Corp. (PROK) Presents At Citi's Biopharma Back To School Conference Transcript

Aug 27, 2025, 7:30 AM EDT - 5 months ago

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

Aug 12, 2025, 4:01 PM EDT - 6 months ago

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

Jul 15, 2025, 7:30 AM EDT - 7 months ago

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

Jul 9, 2025, 11:22 AM EDT - 7 months ago

Trump's latest tariff threats and the impact on markets, ProKidney stock jumps over 500%

Jul 9, 2025, 8:45 AM EDT - 7 months ago

ProKidney: What's Happening With PROK Stock?

Jul 9, 2025, 7:30 AM EDT - 7 months ago

ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

Jul 8, 2025, 5:09 PM EDT - 7 months ago

ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying

Jul 8, 2025, 1:25 PM EDT - 7 months ago

Gold Falls 1%; ProKidney Shares Spike Higher

Jul 8, 2025, 9:05 AM EDT - 7 months ago

Why Is Penny Stock ProKidney Trading Higher On Tuesday?

Jul 8, 2025, 7:00 AM EDT - 7 months ago

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

Jul 1, 2025, 12:43 PM EDT - 7 months ago

ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

May 12, 2025, 4:15 PM EDT - 9 months ago

ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

Mar 17, 2025, 7:30 AM EDT - 11 months ago

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

Jan 31, 2025, 11:08 AM EST - 1 year ago

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

Jan 31, 2025, 6:10 AM EST - 1 year ago

2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment

Nov 26, 2024, 7:30 AM EST - 1 year ago

ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

Nov 12, 2024, 7:30 AM EST - 1 year ago

ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

Nov 5, 2024, 7:30 AM EST - 1 year ago

ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

Oct 14, 2024, 7:30 AM EDT - 1 year ago

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024

Oct 9, 2024, 7:30 AM EDT - 1 year ago

ProKidney to Participate in the UBS Virtual Organ Restoration Day

Sep 3, 2024, 7:30 AM EDT - 1 year ago

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S.

Aug 27, 2024, 7:30 AM EDT - 1 year ago

ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 9, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

Jun 11, 2024, 9:35 PM EDT - 1 year ago

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 4:15 PM EDT - 1 year ago

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 6:30 AM EDT - 1 year ago

ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates

May 29, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Participate in the Jefferies Global Healthcare Conference

May 21, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

May 10, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and First Quarter 2024 Financial Results

Mar 25, 2024, 6:05 AM EDT - 2 years ago

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

Mar 21, 2024, 7:49 PM EDT - 2 years ago

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Feb 29, 2024, 4:05 PM EST - 2 years ago

ProKidney to Participate in Jefferies Biotech on the Bay Summit

Nov 30, 2023, 6:05 AM EST - 2 years ago

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

Nov 21, 2023, 6:05 AM EST - 2 years ago

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference

Nov 16, 2023, 4:40 PM EST - 2 years ago

ProKidney Corp. (PROK) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 6:05 AM EST - 2 years ago

ProKidney Reports Third Quarter Financial Results

Nov 13, 2023, 5:02 PM EST - 2 years ago

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates

Oct 30, 2023, 4:12 PM EDT - 2 years ago

ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023

Sep 5, 2023, 6:05 AM EDT - 2 years ago

ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference

Aug 10, 2023, 4:10 PM EDT - 2 years ago

ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights

Jul 18, 2023, 6:05 AM EDT - 2 years ago

ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC

Biohacker Jan. 26 at 8:17 PM

$PROK 💩

0 · Reply

wavridr Jan. 21 at 7:39 PM

$PROK fuuuuuk! It was so close! 🤬🤬🤬

0 · Reply

wavridr Jan. 21 at 7:14 PM

$PROK finally! This POS is going back to where it belongs🎉💥

0 · Reply

Biohacker Jan. 21 at 4:45 PM

$PROK 💩

0 · Reply

SmartWentCrazy Jan. 20 at 5:04 PM

$PROK

0 · Reply

Biohacker Jan. 20 at 3:53 PM

$PROK 💩

0 · Reply

Strizzball Jan. 18 at 1:04 PM

$PROK https://www.msn.com/en-us/health/other/food-drug-experts-say-new-kidney-cell-therapy-could-transform-chronic-disease-treatment/ar-AA1Uj1VX

0 · Reply

Biohacker Jan. 15 at 3:28 PM

$PROK 💩

0 · Reply

wavridr Jan. 15 at 3:23 PM

$PROK by tmrw this POS will finally be below 2 😁😂😂

0 · Reply

Biohacker Jan. 13 at 5:42 PM

$PROK 💩

0 · Reply

HawkEye828 Jan. 13 at 3:24 PM

$PROK On sale. Time to Buy.

0 · Reply

G101SPM Jan. 12 at 2:34 PM

$PROK $2.29ask. BUY/REVISIT carries SPM 87.02 tag to $12.50 in long term.

0 · Reply

VibeLeaf_46 Jan. 7 at 7:36 PM

$PROK Supply can get spicy fast: float ~43M on ~134.4M shares out. Now stack the receipts: $8.01M rev, 2.53M gallons, Q4 $22.91M, and MoM still green. When attention flips, liquidity dries up and candles get rude. Late chasers always blame “games”… nah, it’s just supply meeting urgency at the worst time. PT $5.50 😈

0 · Reply

SmartWentCrazy Jan. 7 at 4:52 PM

$PROK break above 2.57 is what we are looking for.

0 · Reply

SmartWentCrazy Jan. 7 at 3:17 PM

$PROK

0 · Reply

SmartWentCrazy Jan. 7 at 3:16 PM

$PROK lol

0 · Reply

OfficialStocktwitsUser Jan. 7 at 2:27 AM

$PROK RSI: 56.49, MACD: -0.0485 Vol: 0.14, MA20: 2.30, MA50: 2.46 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

1 · Reply

wavridr Jan. 6 at 7:06 PM

$PROK I've flipped this over 100 times with at least 80% success. Mostly shorting! This has been a POS for the past 6 months! 😂

0 · Reply

wavridr Jan. 6 at 7:01 PM

$PROK lmao I thought u took a L and moved on. Not a single word while it dropped from 2.60 to 2.10 and now it's up a little and suddenly ur a PROKtologist 😂😂

0 · Reply

wavridr Jan. 5 at 4:38 PM

$PROK looks like it could drop below 2 today 😁🎉🔨🔨🔨

1 · Reply

Biohacker Jan. 5 at 4:11 PM

$PROK 💩

0 · Reply

wavridr Jan. 5 at 3:33 PM

$PROK red when everything's green 😂😂

1 · Reply

Market Cap	652.81M
Revenue (ttm)	80,000.00
Net Income (ttm)	-61.19M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-76,487.50%
Debt to Equity Ratio	0.00

Volume	544,835
Avg Vol	1,229,664
Day's Range	N/A - N/A
Shares Out	300.83M
Stochastic %K	26%
Beta	1.79
Analysts	Sell
Price Target	$6.50